fincash logo SOLUTIONS

Fincash » Search » ERIS Lifesciences Ltd

ERIS Lifesciences Ltd

Updated on January 20, 2020

Stock/Share Code - ERIS

Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Below is the details of ERIS ERIS Lifesciences Ltd

Market Cap₹6,338 Cr.
Current Price ₹475.8 as on 10 Dec 19
52 Week High / Low Price₹746 / ₹357.8
Face Value₹1
Stock P/E20.80
Book Value₹96.65
Dividend Yield0.00 %
ROCE25.87 %
ROE28.09 %
Sales Growth (3yrs)13.98 %
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has good consistent profit growth of 35.57% over 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 37.75%
Cons: Though the company is reporting repeated profits, it is not paying out dividend The company has delivered a poor growth of 11.49% over past five years. Tax rate seems low

ERIS Lifesciences Ltd Price Chart

ERIS Lifesciences Ltd Price Chart

ERIS Lifesciences Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma ₹978.6 22.45 ₹8,699.08 Cr. 0.91 ₹116.36 Cr. -6.59 18.13 642.76 23.85
2. ERIS Lifescience 20.80 ₹6,338.29 Cr. 0.00 ₹91.53 Cr. 8.99 13.33 272.90 25.87
3. Caplin Point Lab ₹299.55 11.70 ₹2,375.18 Cr. 0.70 ₹57.27 Cr. 31.66 45.77 227.20 48.53
4. Bliss GVS Pharma ₹155.1 13.64 ₹1,482.58 Cr. 0.70 ₹30.98 Cr. -25.28 -8.02 210.12 26.90
5. Hester Bios ₹1,561.5 32.62 ₹1,333.11 Cr. 0.70 ₹6.52 Cr. -6.46 3.34 44.20 26.65
6. Amrutanjan Healt ₹454.95 47.87 ₹1,304.86 Cr. 0.48 ₹8.4 Cr. 29.43 20.56 74.81 25.42
7. Medicamen Biotec ₹114.95 30.33 ₹374.93 Cr. 0.31 ₹3.84 Cr. 7.87 9.33 35.52 20.15
8. Lincoln Pharma. ₹168 6.95 ₹341.9 Cr. 0.88 ₹18.91 Cr. 26.07 9.83 112.69 22.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

ERIS Lifesciences Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
YOY Sales Growth %%%-12.02%14.78%8.54%16.13%39.58%8.44%26.67%2.24%15.82%13.33%
Material Cost %11.27%13.71%12.62%14.86%14.46%14.75%14.57%14.64%14.62%15.29%17.26%16.54%
Employee Cost %16.04%16.44%18.41%13.54%19.33%18.39%19.2%16.85%18.05%20.68%17.07%17.13%
Operating Profit72556995797284979162100107
OPM %43%33%43%43%43%37%37%40%39%31%38%39%
Other Income67776856101235
Profit before tax7256729877657590875992101
Tax %6%7%3%6%4%11%7%7%10%11%11%10%
Net Profit675270927458708479528292
EPS in Rs4.893.825.096.715.384.

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales Growth %%45.9%24.8%5.29%10.49%17.74%6.69%17.87%%
Material Cost %21.72%23.55%24.57%19.84%19.05%14.97%14.26%14.76%%
Manufacturing Cost %0.37%0.58%0.3%2.44%1.27%5.12%1.95%0.91%%
Employee Cost %14.57%15.66%16.88%22.58%20.21%16.32%17.2%18.6%%
Other Cost %41.85%38.13%41.27%34.36%31.31%25.55%25.06%28.49%%
Operating Profit619288114170271316334360
OPM %22%22%17%21%28%38%42%37%37%
Other Income3143325283229
Profit before tax629089103154274312312340
Tax %30%27%27%19%10%9%6%8%
Net Profit43666583138248294285305
EPS in Rs3,137.104,767.834,721.166,038.048,772.1718.0521.3620.7522.17
Dividend Payout %0%0%0%0%61%0%0%0%

Compounded Sales Growth

  • 5 Years:: 11.49%
  • 3 Years:: 13.98%
  • TTM:: 14.33%

Compounded Profit Growth

  • 5 Years:: 35.57%
  • 3 Years:: 27.96%
  • TTM:: 6.76%

Return on Equity

  • 1 Year:: -25.93%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital0000014141414
Equity Capital0.
Other Liabilities415584869690152197169
Trade Payables15.619.1434.9836.3628.0625.1579.3475.0175.85
Total Liabilities961742683544026641,3971,5291,498
Fixed Assets111564616592490484491
Gross Block14.8720.9173.4885.52108.2113.2532.93551.81
Accumulated Depreciation4.236.019.6224.2643.4121.4343.1967.96
Other Assets66101106110131192361462477
Trade receivables14.4116.622.3123.6225.3641.360.575.9131.2
Cash Equivalents8.863.525.94.918.532.068.816.4710.02
Loans n Advances9.5215.1514.4110.2915.3585.66217.4282.889.57
Other Assets etc9.3713.7718.3717.6732.315.8116.9421.88257.56
Total Assets961742683544026641,3971,5291,498

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity29409092133210236216
Profit from operations62.6495.7288.44113.96171.73273.09319.52336.35
Working Capital Changes-15.8-23.8527.481.42-7.53-11.17-15.57-50.18
Taxes paid-17.47-31.46-26.23-23.01-31.55-52.21-67.67-69.86
Cash from Investing Activity-22-41-85-94-45-199-5932
Fixed Assets Purchased-6-7.24-51.73-13.07-23.22-48.86-24.27-37.42
Fixed Assets Sold00.
Investments purchased-11.23-38.71-35.33-81.37-22.48-110-107.47-77.04
Investments sold000.0100000
Cash from Financing Activity-7-1-01-84-18363-221
Proceeds from Shares00000000.89
Proceeds from Borrowings00010000
Repayment of Borrowings-0.8-0.85-0.390-0.5000
Interest Paid-0.39-0.27-0.04-0.01-0.12-0.11-10.14-21.63
Dividends Paid-5.62000-83.08-16.9100
Net Cash Flow1-15-14-67-2

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %105%56%44%53%62%35%26%
Debtor Days1815161615212931
Inventory Turnover10.9810.6811.0311.7214.7514.5313.56

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in ERIS Lifesciences Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.